X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2446) 2446
sodium chloride symporter inhibitors - therapeutic use (1649) 1649
diuretics (1546) 1546
male (1190) 1190
hypertension - drug therapy (1169) 1169
benzothiadiazines (1109) 1109
female (1100) 1100
middle aged (865) 865
aged (794) 794
antihypertensive agents - therapeutic use (627) 627
adult (525) 525
hypertension (454) 454
drug therapy, combination (451) 451
sodium chloride symporter inhibitors - adverse effects (417) 417
animals (383) 383
adrenergic beta-antagonists - therapeutic use (376) 376
sodium potassium chloride symporter inhibitors - therapeutic use (361) 361
blood pressure - drug effects (349) 349
angiotensin-converting enzyme inhibitors - therapeutic use (334) 334
treatment outcome (309) 309
diuretics - therapeutic use (300) 300
hydrochlorothiazide - therapeutic use (290) 290
risk factors (274) 274
heart failure - drug therapy (273) 273
hypertension - physiopathology (266) 266
medicine, general & internal (258) 258
pharmacology & pharmacy (255) 255
cardiac & cardiovascular systems (247) 247
calcium channel blockers - therapeutic use (235) 235
sodium chloride symporter inhibitors - administration & dosage (222) 222
peripheral vascular disease (220) 220
aged, 80 and over (216) 216
time factors (200) 200
heart failure (191) 191
hypertension - complications (191) 191
blood-pressure (190) 190
mortality (185) 185
clinical trials as topic (182) 182
sodium chloride symporter inhibitors - pharmacology (177) 177
antihypertensive agents - adverse effects (175) 175
risk (172) 172
blood pressure (168) 168
double-blind method (164) 164
rats (160) 160
furosemide - therapeutic use (159) 159
drug therapy (150) 150
hydrochlorothiazide (144) 144
furosemide (137) 137
urology & nephrology (132) 132
dose-response relationship, drug (128) 128
therapy (125) 125
antihypertensive agents - administration & dosage (119) 119
heart failure - physiopathology (119) 119
sodium (119) 119
diuretics - adverse effects (118) 118
follow-up studies (118) 118
age factors (117) 117
retrospective studies (117) 117
prospective studies (114) 114
randomized controlled trials as topic (111) 111
hypertension - blood (109) 109
analysis (105) 105
sodium potassium chloride symporter inhibitors - adverse effects (105) 105
sodium - metabolism (103) 103
thiazides (103) 103
research (102) 102
calcium - urine (101) 101
prognosis (100) 100
sodium potassium chloride symporter inhibitors - administration & dosage (99) 99
health aspects (95) 95
hypokalemia - chemically induced (95) 95
adolescent (92) 92
care and treatment (92) 92
prevention (92) 92
medicine & public health (91) 91
mice (91) 91
antihypertensive agents - pharmacology (90) 90
drug combinations (88) 88
outcomes (86) 86
abridged index medicus (84) 84
diuretics - pharmacology (84) 84
management (84) 84
physiology (83) 83
potassium - blood (82) 82
sodium potassium chloride symporter inhibitors - pharmacology (81) 81
spironolactone - therapeutic use (80) 80
hydrochlorothiazide - administration & dosage (77) 77
trial (77) 77
hypertension - diagnosis (76) 76
physiological aspects (74) 74
loop diuretics (73) 73
prevalence (73) 73
practice guidelines as topic (72) 72
research article (71) 71
neurosciences (70) 70
cohort studies (69) 69
heart failure - mortality (69) 69
drug interactions (67) 67
vasodilator agents - therapeutic use (67) 67
association (66) 66
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2333) 2333
German (93) 93
French (61) 61
Russian (56) 56
Japanese (53) 53
Italian (36) 36
Norwegian (22) 22
Spanish (22) 22
Polish (13) 13
Danish (10) 10
Chinese (8) 8
Hungarian (7) 7
Portuguese (7) 7
Czech (4) 4
Swedish (4) 4
Croatian (2) 2
Hebrew (2) 2
Romanian (2) 2
Finnish (1) 1
Slovak (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1469-493X, 04/2018, Volume 2018, Issue 4, p. CD001841
...: What class of drug to use first‐line? This review attempted to answer that question. Objectives To quantify the mortality and morbidity effects from different first... 
Hypertension | Kidney disease | Treatment: pharmacological | Stroke | Sodium Chloride Symporter Inhibitors | Pharmacological Therapies | Angiotensin‐Converting Enzyme Inhibitors | Randomized Controlled Trials as Topic | General Pharmacotherapies | Calcium Channel Blockers | Coronary Disease | Adrenergic beta‐Antagonists | Antihypertensive Agents | Heart & circulation | Thiazides | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | Angiotensin-Converting Enzyme Inhibitors [therapeutic use] | Antihypertensive Agents [adverse effects; therapeutic use] | Coronary Disease [prevention & control] | Humans | ELDERLY PROGRAM SHEP | CONVERTING-ENZYME-INHIBITION | Sodium Chloride Symporter Inhibitors [therapeutic use] | Adrenergic beta-Antagonists [therapeutic use] | EUROPEAN-WORKING-PARTY | PROSPECTIVELY-DESIGNED OVERVIEWS | Calcium Channel Blockers [therapeutic use] | SERUM URIC-ACID | MEDICINE, GENERAL & INTERNAL | AUSTRALIAN THERAPEUTIC TRIAL | HIGH-BLOOD-PRESSURE | ISOLATED SYSTOLIC HYPERTENSION | PLACEBO-CONTROLLED TRIAL | Stroke [prevention & control] | CORONARY-HEART-DISEASE | Hypertension [drug therapy; mortality] | Stroke - prevention & control | Middle Aged | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Sodium Chloride Symporter Inhibitors - therapeutic use | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Coronary Disease - prevention & control | Thiazides - adverse effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypertension - mortality | Adrenergic beta-Antagonists - therapeutic use | Thiazides - therapeutic use
Journal Article
Expert Review of Cardiovascular Therapy, ISSN 1477-9072, 06/2010, Volume 8, Issue 6, pp. 793 - 802
Journal Article
Journal Article
American Journal of Medicine, The, ISSN 0002-9343, 2016, Volume 129, Issue 12, pp. 1299 - 1306
Journal Article
Lancet neurology, ISSN 1474-4422, 2015, Volume 14, Issue 5, pp. 469 - 477
Journal Article
Circulation (New York, N.Y.), ISSN 0009-7322, 03/2006, Volume 113, Issue 9, pp. 1213 - 1225
Journal Article
Hypertension (Dallas, Tex. 1979), ISSN 0194-911X, 02/2007, Volume 49, Issue 2, pp. 276 - 284
Thiazide diuretics, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers all cause reactive rises in plasma renin activity... 
Hypertension | Aliskiren | Renin inhibitor | Renin-angiotensin-aldosterone system | Combination therapy | Plasma renin activity | Ambulatory blood pressure measurement | SYSTEM | plasma renin activity | DESIGN | ANTAGONIST | MYOCARDIAL-INFARCTION | aliskiren | TISSUE | ambulatory blood pressure measurement | SOCIETY | renin-angiotensin-aldosterone system | RISK-FACTOR | combination therapy | PERIPHERAL VASCULAR DISEASE | renin inhibitor | ESSENTIAL-HYPERTENSION | ALDOSTERONE | hypertension | Angiotensin II Type 1 Receptor Blockers - adverse effects | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Biphenyl Compounds - adverse effects | Amides | Hypertension - drug therapy | Male | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Biphenyl Compounds - therapeutic use | Hypertension - blood | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Aged, 80 and over | Adult | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Drug Therapy, Combination | Hypertension - diagnosis | Ramipril - adverse effects | Hydrochlorothiazide - adverse effects | Fumarates - therapeutic use | Fumarates - adverse effects | Antihypertensive Agents - therapeutic use | Renin - blood | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Antihypertensive Agents - blood | Fumarates - blood | Renin - antagonists & inhibitors | Tetrazoles - therapeutic use | Aged | Patient Compliance | Tetrazoles - adverse effects | Blood Pressure Monitoring, Ambulatory | Hydrochlorothiazide - therapeutic use
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 11/2018, Volume 2018, Issue 11, p. CD008170
.... Despite widespread use for hypertension, the efficacy and safety of RAS inhibitors compared to other antihypertensive drug classes remains unclear... 
Hypertension | Kidney disease | Stroke | Renin‐Angiotensin System | Sodium Chloride Symporter Inhibitors | Cause of Death | Angiotensin‐Converting Enzyme Inhibitors | Randomized Controlled Trials as Topic | Calcium Channel Blockers | Myocardial Infarction | Management/treatment of Specific sub‐types of Hypertensive Patients | Management of specific sub‐types of hypertensive patients | Heart Failure | Kidney Failure, Chronic | Antihypertensive Agents | Heart & circulation | Medicine General & Introductory Medical Sciences | Treatment of essential Hypertension | Patients with other cardiovascular risk factors (smoking; diabetes; high serum cholesterol levels; arterial fibrillation) | CALCIUM-CHANNEL BLOCKER | INTIMA-MEDIA THICKNESS | LIPID-LOWERING TREATMENT | DEPENDENT DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | END-POINT REDUCTION | CONVERTING ENZYME-INHIBITION | DOUBLE-BLIND | BLOOD-PRESSURE CONTROL | QUALITY-OF-LIFE | LEFT-VENTRICULAR HYPERTROPHY | Myocardial Infarction - epidemiology | Stroke - prevention & control | Calcium Channel Blockers - adverse effects | Humans | Calcium Channel Blockers - therapeutic use | Hypertension - drug therapy | Sodium Chloride Symporter Inhibitors - adverse effects | Sodium Chloride Symporter Inhibitors - therapeutic use | Antihypertensive Agents - therapeutic use | Antihypertensive Agents - adverse effects | Heart Failure - prevention & control | Stroke - chemically induced | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Kidney Failure, Chronic - epidemiology | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Renin-Angiotensin System - drug effects | Aged | Hypertension - mortality | Heart Failure - chemically induced | Heart Failure - mortality
Journal Article